Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |